Inferior Vena Cava Rupture Caused by Balloon Angioplasty During the Treatment of Budd–Chiari Syndrome

Objective Percutaneous transluminal balloon angioplasty (PTA) is the main treatment option for Budd–Chiari syndrome (BCS) with inferior vena cava (IVC) obstruction. However, IVC rupture caused by PTA has never been reported. Materials and Methods Between August 2004 and December 2016, a consecutive...

Full description

Saved in:
Bibliographic Details
Published in:Cardiovascular and interventional radiology 2019-10, Vol.42 (10), p.1398-1404
Main Authors: Ding, Peng-Xu, Han, Xin-Wei, Liu, Chao, Ding, Jia-Yin, Lee, Edward Wolfgang
Format: Article
Language:English
Subjects:
Adult
Aged
Angioplasty
Angioplasty, Balloon - adverse effects
Arterial Occlusive Diseases - complications
Balloon treatment
Budd-Chiari Syndrome - complications
Budd-Chiari Syndrome - therapy
Cardiology
Clinical Investigation
Extravasation
Female
Humans
Imaging
Implants
LIVER
Male
Medical equipment
Medicine
Medicine & Public Health
Middle Aged
Nuclear Medicine
PATIENTS
Radiology
RADIOLOGY AND NUCLEAR MEDICINE
Retrospective Studies
REVIEWS
Rupture
Rupture - etiology
RUPTURES
Rupturing
Stents
SURGERY
Surgical implants
Treatment Outcome
Ultrasound
VASCULAR DISEASES
VEINS
Vena Cava, Inferior - injuries
Venous Interventions
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective Percutaneous transluminal balloon angioplasty (PTA) is the main treatment option for Budd–Chiari syndrome (BCS) with inferior vena cava (IVC) obstruction. However, IVC rupture caused by PTA has never been reported. Materials and Methods Between August 2004 and December 2016, a consecutive cohort of 617 BCS patients with obstructed IVC who underwent PTA with or without stent placement were reviewed retrospectively to identify IVC rupture. Pre- and post-procedural imaging data, clinical and procedural technical data were analyzed. Results Of the 617 BCS patients, five patients had IVC rupture caused by PTA (0.81%). Four of these patients had retroperitoneal, intra-hepatic IVC rupture without extravasation into abdominal cavity which was successfully managed conservatively. One patient had supra-hepatic IVC rupture into the pericardial cavity which was surgically treated. Conclusion IVC rupture is a rare complication of PTA treatment of BCS and most commonly located at the intra-hepatic IVC caused by oversized balloons which does not require additional treatment.
ISSN:0174-1551
1432-086X
DOI:10.1007/s00270-019-02292-9